Recent News

• 04.25.2025 - Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025
• 04.25.2025 - Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025
• 03.31.2025 - Repare Therapeutics Announces Leadership Transitions
• 03.31.2025 - Repare Therapeutics Announces Leadership Transitions
• 03.07.2025 - Repare Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 03.07.2025 - Repare Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 03.03.2025 - Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results
• 03.03.2025 - Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Recent Filings

• 04.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.31.2025 - EX-99.1 EX-99.1
• 03.31.2025 - 8-K Current report
• 03.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.06.2025 - 4 Statement of changes in beneficial ownership of securities